Tech Company Financing Transactions

Nutcracker Therapeutics Funding Round

Arch Venture Partners and private investors participated in a $167 million Series C funding round for Nutcracker Therapeutics. The round was announced on 3/14/2022.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series C

Arch Venture Partners (Lead Investor) (Robert Nelsen)

Proceeds Purpose
The funds will allow the company to expand and advance its pipeline of mRNA medicines for cancer, in addition to further refining its RNA manufacturing platform and the underlying technology.

Company Information

Company Status
Private & Independent
Mailing Address
5858 Horton St. 540
Emeryville, CA 94608
Email Address
Nutcracker Therapeutics is bringing the combined power of high-technology engineering and advanced biosynthesis to RNA therapeutics through its push-button mRNA synthesis and formulation platform. Armed with this high-tech advantage, we will advance mRNA therapeutics into the clinic and engage in strategic partnerships with clinical institutions and pharmaceutical/biotech companies.
Nutcracker Therapeutics LinkedIn Company Profile
Social Media
Nutcracker Therapeutics Company Twitter Account
Company News
Nutcracker Therapeutics News
Nutcracker Therapeutics on Facebook
Nutcracker Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Igor Khandros
  Igor Khandros LinkedIn Profile  Igor Khandros Twitter Account  Igor Khandros News  Igor Khandros on Facebook
Chief Financial Officer
James Zhu
  James Zhu LinkedIn Profile  James Zhu Twitter Account  James Zhu News  James Zhu on Facebook
Chief Operating Officer
Madhavan Balachandran
  Madhavan Balachandran LinkedIn Profile  Madhavan Balachandran Twitter Account  Madhavan Balachandran News  Madhavan Balachandran on Facebook
Chief Technical Officer
Benjamin Eldridge
  Benjamin Eldridge LinkedIn Profile  Benjamin Eldridge Twitter Account  Benjamin Eldridge News  Benjamin Eldridge on Facebook
Vice President
Swami Murugappan
  Swami Murugappan LinkedIn Profile  Swami Murugappan Twitter Account  Swami Murugappan News  Swami Murugappan on Facebook
Vice President
Bruce Wu
  Bruce Wu LinkedIn Profile  Bruce Wu Twitter Account  Bruce Wu News  Bruce Wu on Facebook
VP - Bus. Development
Kevin Hambly
  Kevin Hambly LinkedIn Profile  Kevin Hambly Twitter Account  Kevin Hambly News  Kevin Hambly on Facebook
VP - Human Resources
Kathryn Blystone
  Kathryn Blystone LinkedIn Profile  Kathryn Blystone Twitter Account  Kathryn Blystone News  Kathryn Blystone on Facebook
VP - R & D
Samuel Deutsch
  Samuel Deutsch LinkedIn Profile  Samuel Deutsch Twitter Account  Samuel Deutsch News  Samuel Deutsch on Facebook



Browse more venture capital transactions:

Prev: 3/14/2022: Gauntlet venture capital transaction
Next: 3/14/2022: SupPlant venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary